DATA Fundamental Analysis - DATRIX SPA

Name: DATRIX SPA (DATA) Stock
Brand: DATRIX SPA
Rating: 4.5 (3 reviews)

Fundamental Rating

Overall DATA gets a fundamental rating of 2 out of 10. We evaluated DATA against 109 industry peers in the Software industry. DATA has a bad profitability rating. Also its financial health evaluation is rather negative. DATA is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

DATA had negative earnings in the past year.

DATA had a positive operating cash flow in the past year.

In the past 5 years DATA always reported negative net income.

In multiple years DATA reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of DATA (-9.22%) is worse than 77.98% of its industry peers.

DATA's Return On Equity of -21.49% is on the low side compared to the rest of the industry. DATA is outperformed by 74.31% of its industry peers.

		Industry Rank	Sector Rank
ROA	-9.22%
ROE	-21.49%
ROIC	N/A

ROA(3y)-8.87%

ROA(5y)-9.19%

ROE(3y)-20.9%

ROE(5y)-21.68%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DATA has a better Gross Margin (110.63%) than 99.08% of its industry peers.

DATA's Gross Margin has been stable in the last couple of years.

DATA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	110.63%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.39%

GM growth 5Y-1.08%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DATA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DATA has been increased compared to 1 year ago.

DATA has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, DATA has a worse debt to assets ratio.

2.2 Solvency

DATA has an Altman-Z score of 0.68. This is a bad value and indicates that DATA is not financially healthy and even has some risk of bankruptcy.

DATA's Altman-Z score of 0.68 is on the low side compared to the rest of the industry. DATA is outperformed by 76.15% of its industry peers.

DATA has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.

DATA has a Debt to Equity ratio (0.32) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.32
Debt/FCF	N/A
Altman-Z	0.68

ROIC/WACCN/A

WACC8.31%

2.3 Liquidity

DATA has a Current Ratio of 1.38. This is a normal value and indicates that DATA is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.38, DATA is in line with its industry, outperforming 48.62% of the companies in the same industry.

DATA has a Quick Ratio of 1.38. This is a normal value and indicates that DATA is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of DATA (1.38) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.38
Quick Ratio	1.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.28% over the past year.

The Revenue has grown by 17.40% in the past year. This is quite good.

The Revenue has been growing by 28.01% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)13.28%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.3%

Revenue 1Y (TTM)17.4%

Revenue growth 3Y17.38%

Revenue growth 5Y28.01%

Sales Q2Q%7.42%

3.2 Future

Based on estimates for the next years, DATA will show a decrease in Earnings Per Share. The EPS will decrease by -5.04% on average per year.

Based on estimates for the next years, DATA will show a small growth in Revenue. The Revenue will grow by 4.01% on average per year.

EPS Next Y56.69%

EPS Next 2Y-47.05%

EPS Next 3Y-28.48%

EPS Next 5Y-5.04%

Revenue Next Year41.8%

Revenue Next 2Y-13.26%

Revenue Next 3Y-1.3%

Revenue Next 5Y4.01%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DATA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year DATA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DATA is valued a bit cheaper than the industry average as 69.72% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	12.95

4.3 Compensation for Growth

A cheap valuation may be justified as DATA's earnings are expected to decrease with -28.48% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-47.05%

EPS Next 3Y-28.48%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DATA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DATRIX SPA

BIT:DATA (11/21/2025, 7:00:00 PM)

1.835

-0.11 (-5.66%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners20.81%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap18.00M

Revenue(TTM)18.35M

Net Income(TTM)-2.22M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.98
P/FCF	N/A
P/OCF	27.22
P/B	1.74
P/tB	N/A
EV/EBITDA	12.95

EPS(TTM)-0.23

EYN/A

EPS(NY)-0.04

Fwd EYN/A

FCF(TTM)-0.2

FCFYN/A

OCF(TTM)0.07

OCFY3.67%

SpS1.87

BVpS1.05

TBVpS-0.06

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.22%
ROE	-21.49%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	110.63%
FCFM	N/A

ROA(3y)-8.87%

ROA(5y)-9.19%

ROE(3y)-20.9%

ROE(5y)-21.68%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.39%

GM growth 5Y-1.08%

F-Score3

Asset Turnover0.76

Health

		Industry Rank	Sector Rank
Debt/Equity	0.32
Debt/FCF	N/A
Debt/EBITDA	2.12
Cap/Depr	76.7%
Cap/Sales	14.06%
Interest Coverage	N/A
Cash Conversion	41.85%
Profit Quality	N/A
Current Ratio	1.38
Quick Ratio	1.38
Altman-Z	0.68

F-Score3

WACC8.31%

ROIC/WACCN/A

Cap/Depr(3y)100.41%

Cap/Depr(5y)130.93%

Cap/Sales(3y)20.68%

Cap/Sales(5y)23.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)13.28%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.3%

EPS Next Y56.69%

EPS Next 2Y-47.05%

EPS Next 3Y-28.48%

EPS Next 5Y-5.04%

Revenue 1Y (TTM)17.4%

Revenue growth 3Y17.38%

Revenue growth 5Y28.01%

Sales Q2Q%7.42%

Revenue Next Year41.8%

Revenue Next 2Y-13.26%

Revenue Next 3Y-1.3%

Revenue Next 5Y4.01%

EBIT growth 1Y36.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year139.85%

EBIT Next 3Y-0.1%

EBIT Next 5Y10.2%

FCF growth 1Y59.83%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y157.26%

OCF growth 3YN/A

OCF growth 5YN/A

DATRIX SPA / DATA.MI FAQ

What is the ChartMill fundamental rating of DATRIX SPA (DATA.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DATA.MI.

What is the valuation status for DATA stock?

ChartMill assigns a valuation rating of 1 / 10 to DATRIX SPA (DATA.MI). This can be considered as Overvalued.

Can you provide the profitability details for DATRIX SPA?

DATRIX SPA (DATA.MI) has a profitability rating of 2 / 10.

What is the financial health of DATRIX SPA (DATA.MI) stock?

The financial health rating of DATRIX SPA (DATA.MI) is 2 / 10.

DATRIX SPA (DATA.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DATRIX SPA / DATA.MI FAQ

What is the ChartMill fundamental rating of DATRIX SPA (DATA.MI) stock?

What is the valuation status for DATA stock?

Can you provide the profitability details for DATRIX SPA?

What is the financial health of DATRIX SPA (DATA.MI) stock?